Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle

This publication has 27 references indexed in Scilit:

• Analyses of the combination of 6-MP and dasatinib in cell culture
  International Journal of Oncology, 2013
• Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools
  Drug Discovery Today, 2013
• Systematic identification of synergistic drug pairs targeting HIV
  Nature Biotechnology, 2012
• Identification of a Broadly Cross-Reacting and Neutralizing Human Monoclonal Antibody Directed against the Hepatitis C Virus E2 Protein
  Journal of Virology, 2008
• Preclinicalversusclinical drug combination studies
  Leukemia & Lymphoma, 2008
• Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
  Pharmacological Reviews, 2006
• Passive antibody therapy for infectious diseases
  Nature Reviews Microbiology, 2004
• Synergy, antagonism, and what the chequerboard puts between them
  Journal of Antimicrobial Chemotherapy, 2003
• Susceptibilities of Herpes Simplex Viruses to Penciclovir and Acyclovir in Eight Cell Lines
  Antimicrobial Agents and Chemotherapy, 2002
• Über Kombinationswirkungen
  Naunyn-Schmiedeberg's Archives of Pharmacology, 1926